Summary

The North American dialysis equipment market is a beacon of innovation, revolutionising the field of renal care with its cutting-edge developments and steadfast commitment to improving patient outcomes. This vibrant market pulsates with a synergy of breakthrough research, pioneering technology, and a genuine dedication to serving the complicated requirements of people suffering from renal illnesses. It spans the wide expanses of Canada, the United States, and Mexico. The North American dialysis equipment market serves as a cradle for innovative solutions, with an uncompromising focus on boosting the quality of life for people navigating the difficulties of kidney-related disorders. It includes a wide range of cutting-edge devices, such as hemodialysis machines, peritoneal dialysis equipment, dialyzers, and a plethora of associated consumables, all meticulously designed to improve efficacy, increase patient comfort, and improve access to life-sustaining treatments. Furthermore, the market environment is defined by an unyielding commitment to encouraging inclusivity and accessibility, ensuring that the advantages of these cutting-edge innovations reach people from all socioeconomic levels. As the prevalence of renal disorders rises, the North American dialysis equipment market appears as a ray of hope, relentlessly working to bridge the gap between demand and supply while promoting affordability without sacrificing the critical aspect of quality care. Home-based dialysis therapies are gaining popularity because of their convenience, flexibility, and possible cost-effectiveness. This tendency supports demand for portable and simple-to-use dialysis equipment, encouraging patient autonomy and lowering reliance on healthcare facilities. The steady increase in public and private healthcare investment spent on renal care infrastructure and sophisticated dialysis technologies acts as a catalyst for market expansion. Investments in research and development create technical breakthroughs and increase market competitiveness.

According to the research report "North America Dialysis Equipments Market Outlook, 2028," published by Bonafide Research, the North America Dialysis Equipments market is predicted to grow with more than 5% CAGR from 2023 to 2028. Government initiatives, favourable reimbursement rules, and expanded awareness programmes aimed at renal health all play an important role. These policies not only encourage the use of modern dialysis equipment but also make it more accessible to patients from a variety of socioeconomic backgrounds. Dialysis equipment integration with digital health technology, telemedicine, and remote monitoring systems improves patient care and treatment outcomes. Connectivity enables real-time data analysis, allowing healthcare providers to provide personalised and prompt interventions, hence improving patient management and lowering complications. North America is a centre for cutting-edge healthcare technology innovation and research. The region has a strong research and development infrastructure, which fosters an innovative culture that constantly pushes the boundaries of dialysis equipment technology. North America, particularly the United States, has strict regulatory standards in place to ensure product safety and efficacy. The FDA (Food and Drug Administration) standards create a high standard for dialysis equipment approval and commercialization, creating trust and confidence among customers and healthcare professionals. North America's ageing population contributes to the prevalence of chronic diseases, especially kidney-related ailments. Demand for dialysis equipment and related services are being driven by this demographic trend. The complexity and diversity of North America's healthcare reimbursement systems have a considerable impact on the dialysis equipment market. Private insurance, government-funded programmes like Medicare and Medicaid in the United States and provincial health systems in Canada all influence market dynamics and patient access to dialysis equipment and treatments. The region serves as a hub for clinical research and trials, which aid in the development and validation of new dialysis systems. The participation of North American healthcare facilities and patients in these studies hastens the market release of breakthrough technology.

Based on country report consist three major countries, United States, Canada and Mexico. Among them United States accounts for largest market in North America with significant market share.

The dialysis equipment market in the United States is an important component of the larger landscape of healthcare technology, reflecting shifting demands and advances in renal treatment. This market, which comprises a wide range of novel equipment and technologies, is crucial in assisting in the treatment of persons with renal illnesses, providing life-sustaining medications, and improving quality of life. The burden of kidney disease in the United States is enormous, with chronic kidney disease (CKD) and end-stage renal disease (ESRD) being more common. This trend is influenced by an ageing population, higher rates of diabetes and hypertension (the leading causes of renal disease), and lifestyle factors. There are approximately 500,000 dialysis patients in the United States, and the number is rapidly increasing, therefore increasing demand for dialysis equipment. Renal replacement therapies, such as hemodialysis and peritoneal dialysis, remain significant treatment choices for patients with kidney failure. The market is increasingly focused on enhancing the efficiency, safety, and patient experience of these medications. Dialysis equipment advancements aim to alleviate difficulties and improve outcomes for patients receiving these life-sustaining procedures. The United States has an advanced healthcare infrastructure, which includes a network of hospitals, clinics, and specialty dialysis units. This infrastructure ensures that kidney care services are widely available across the country by providing access to innovative medical technologies, such as cutting-edge dialysis equipment.

Based on product type market is bifurcated into hemodialysis devices, peritoneal dialysis equipment and others. Among them hemodialysis devices product type is expected to dominate the North America dialysis equipment market.

Hemodialysis equipment's technological prowess serves as a beacon of innovation in the market. These machines are always being improved, with sophisticated features aimed at improving treatment efficacy, ensuring patient safety, and expediting the dialysis procedure. The constant quest for perfection in hemodialysis equipment is exemplified by cutting-edge improvements such as improved biocompatible materials, precision in fluid management, enhanced monitoring capabilities, and integration with digital health technology. The ease of use, efficiency, and proven efficacy of hemodialysis procedures in clinical settings, together with the extensive infrastructure that supports in-center treatments, place these devices as a cornerstone of renal care. Furthermore, the ageing population and increased prevalence of comorbidities such as diabetes and hypertension lead to increased demand for hemodialysis therapy, bolstering the market dominance of related equipment. In addition to these factors, the evolving reimbursement landscape and healthcare policies in North America favor the utilization of hemodialysis devices. The well-established reimbursement mechanisms, coupled with healthcare initiatives supporting the expansion of in-center dialysis facilities, create an environment conducive to the widespread adoption of hemodialysis devices across healthcare institutions. The dominance of hemodialysis devices is further strengthened by manufacturer’s strategic focus on R&D, which drives continual innovation and the introduction of novel features that cater to changing patient needs and clinician preferences. These developments not only improve treatment outcomes but also emphasise patient comfort, convenience of use, and operational efficiency, increasing the market attractiveness of hemodialysis systems in North America.

In terms of end user market is divided into hospital, clinics, ambulatory surgical centers, and home care settings. Hospitals are major end users of dialysis equipments in North America with significant market share. Based on indication market is segmented into kidney failure, cardiovascular disorders & hypertension, diabetes, pregnancy, cancer, wound care, movement disorders, respiratory diseases, and other indications.

Hospitals function as entire healthcare hubs, complete with specialised departments and resources required to provide complicated and continuous care to patients, including those requiring dialysis. They provide a wide range of services, such as emergency care, surgery, and specialised units such as nephrology departments, which house dialysis units. Hospitals frequently care for patients with a wide range of difficult medical illnesses, including those with end-stage renal disease who require dialysis. Hospital infrastructure and experience are well-suited to managing critical situations, offering round-the-clock care and access to modern dialysis equipment. Hospitals provide both inpatient and outpatient dialysis services, giving patients more treatment alternatives. While inpatient services are designed for hospitalised patients who require immediate care, outpatient units give ongoing dialysis treatments to patients who attend hospitals on a regular basis. Hospitals frequently interact with research organisations and universities, creating an environment that fosters innovation and the progress of dialysis equipment. This collaboration between healthcare facilities and research organisations helps to improve and create innovative technologies in renal care. Dialysis equipments are commonly used n kidney failure and kidney disorders treatment. North America has a high prevalence of CKD and related renal diseases. Factors such as an ageing population, a high prevalence of diabetes, hypertension, and lifestyle-related disorders all contribute to an increase in the prevalence of kidney diseases, necessitating therapies such as dialysis. Dialysis is recommended as a standard of therapy for those with advanced renal failure in North America, according to established clinical guidelines and best practices. These guidelines compel healthcare practitioners to deliver dialysis treatments as a critical intervention in the treatment of kidney problems.

Companies Covered in this report:
Baxter International Inc., Nipro Corporation, B. Braun Melsungen AG, Medtronic plc , Terumo Corporation , Asahi Kasei Corporation ,Toray Industries, Inc, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Becton, Dickinson and Company, Outset Medical, Teleflex Incorporated.

Considered in this report:

• Geography: North America
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• North America Dialysis Equipments market Outlook with its value and forecast along with its segments
• Country-wise Dialysis Equipments market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• United States
• Canada
• Mexico

By Product Type:
• Hemodialysis Devices
• Peritoneal Dialysis Equipments
• Others

By End User:

• Hospital
• Clinics
• Ambulatory Surgical centers
• Home Care Settings

By Indication:

• Kidney failure
• Cardiovascular Disorders & Hypertension
• Diabetes
• Pregnancy
• Cancer
• Wound Care
• Movement Disorders
• Respiratory Diseases
• Other Indications

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Dialysis Equipments industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents